Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells

Fertility and Sterility

Volumn 89, Issue 5 SUPPL., 2008, Pages 1344-1347

  Fu, Li ^a   Osuga, Yutaka ^a   Morimoto, Chieko ^a   Hirata, Tetsuya ^a   Hirota, Yasushi ^a   Yano, Tetsu ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

cell cycle; Dienogest; endometriosis; proliferation

Indexed keywords

BROXURIDINE; DIENOGEST; DNA;

ADULT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL ISOLATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MITOSIS INHIBITION; OVARY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROMA CELL;

ADULT; BROMODEOXYURIDINE; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CONTRACEPTIVES, ORAL; DNA; DRUG EVALUATION, PRECLINICAL; ENDOMETRIOSIS; FEMALE; G0 PHASE; G1 PHASE; HUMANS; NANDROLONE; OVARIAN DISEASES; STROMAL CELLS;

EID: 43549106789     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.042     Document Type: Article

References (29)

1. Momoeda M., Taketani Y., Terakawa N., Hoshiai H., Tanaka K., Tsutsumi O., et al. Is endometriosis really associated with pain?. Gynecol Obstet Invest 54 Suppl 1 (2002) 18-21
2. Osuga Y., Koga K., Tsutsumi O., Yano T., Maruyama M., Kugu K., et al. Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Invest 53 Suppl 1 (2002) 33-39
3. Foster R.H., and Wilde M.I. Dienogest. Drugs 56 (1998) 825-833
4. Katsuki Y., Takano Y., Futamura Y., Shibutani Y., Aoki D., Udagawa Y., et al. Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. Eur J Endocrinol 138 (1998) 216-226
5. Kohler G., Goretzlehner G., and Amon I. Therapy of endometriosis with dienogest. Zentralbl Gynakol 109 (1987) 795-801
6. Kohler G., Goretzlehner G., and Brachmann K. Lipid metabolism during treatment of endometriosis with the progestin dienogest. Acta Obstet Gynecol Scand 68 (1989) 633-635
7. Cosson M., Querleu D., Donnez J., Madelenat P., Konincks P., Audebert A., et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 77 (2002) 684-692
8. Schindler A.E., Christensen B., Henkel A., Oettel M., and Moore C. High-dose pilot study with the novel progestogen dienogestin patients with endometriosis. Gynecol Endocrinol 22 (2006) 9-17
9. Okada H., Nakajima T., Yoshimura T., Yasuda K., and Kanzaki H. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod 7 (2001) 341-347
10. Matsuzaki S., Canis M., Pouly J.L., Botchorishvili R., Dechelotte P.J., and Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil Steril 86 (2006) 548-553
11. Wu Y., Kajdacsy-Balla A., Strawn E., Basir Z., Halverson G., Jailwala P., et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 147 (2006) 232-246
12. Fujimoto J., Hirose R., Sakaguchi H., and Tamaya T. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod 5 (1999) 742-747
13. Misao R., Iwagaki S., Fujimoto J., Sun W., and Tamaya T. Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis. Horm Res 52 (1999) 30-34
14. Hirota Y., Osuga Y., Hirata T., Harada M., Morimoto C., Yoshino O., et al. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 20 (2005) 3547-3553
15. Hirota Y., Osuga Y., Hirata T., Yoshino O., Koga K., Harada M., et al. Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis. J Clin Endocrinol Metab 90 (2005) 3673-3679
16. Hirota Y., Osuga Y., Hirata T., Koga K., Yoshino O., Harada M., et al. Evidence for the presence of protease-activated receptor 2 and its possible implication in remodeling of human endometrium. J Clin Endocrinol Metab 90 (2005) 1662-1669
17. Morimoto C., Osuga Y., Yano T., Takemura Y., Harada M., Hirata T., et al. GnRH II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 20 (2005) 3212-3218
18. Bulun S.E., Cheng Y.H., Yin P., Imir G., Utsunomiya H., Attar E., et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248 (2006) 94-103
19. Neulen J., Wagner B., Runge M., and Breckwoldt M. Effect of progestins, androgens, estrogens and antiestrogens on 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro. Arch Gynecol 240 (1987) 225-232
20. Surrey E.S., and Halme J. Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro. Fertil Steril 58 (1992) 273-278
21. Kao L.C., Germeyer A., Tulac S., Lobo S., Yang J.P., Taylor R.N., et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144 (2003) 2870-2881
22. Osteen K.G., Bruner-Tran K.L., Keller N.R., and Eisenberg E. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Ann N Y Acad Sci 955 (2002) 37-47
23. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83 (1998) 4474-4480
24. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85 (2000) 2897-2902
25. Lee W.S., Liu C.W., Juan S.H., Liang Y.C., Ho P.Y., and Lee Y.H. Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells. Endocrinology 144 (2003) 2785-2790
26. Shiozawa T., Horiuchi A., Kato K., Obinata M., Konishi I., Fujii S., et al. Up-regulation of p27Kip1 by progestins is involved in the growth suppression of the normal and malignant human endometrial glandular cells. Endocrinology 142 (2001) 4182-4188
27. Nasu K., Nishida M., Ueda T., Takai N., Bing S., Narahara H., et al. Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis. Mol Hum Reprod 11 (2005) 817-823
28. Nishida M., Nasu K., Ueda T., Yuge A., Takai N., and Narahara H. Beta-hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study. Hum Reprod 21 (2006) 2850-2856
29. Horie S., Harada T., Mitsunari M., Taniguchi F., Iwabe T., and Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril 83 (2005) 1530-1535